153 related articles for article (PubMed ID: 25275060)
1. Identifying melanoma patients with 1-3 brain metastases who may benefit from whole-brain irradiation in addition to radiosurgery.
Huttenlocher S; Sehmisch L; Schild SE; Blank O; Hornung D; Rades D
Anticancer Res; 2014 Oct; 34(10):5589-92. PubMed ID: 25275060
[TBL] [Abstract][Full Text] [Related]
2. Radiosurgery alone versus radiosurgery plus whole-brain irradiation for very few cerebral metastases from lung cancer.
Rades D; Huttenlocher S; Hornung D; Blanck O; Schild SE
BMC Cancer; 2014 Dec; 14():931. PubMed ID: 25496194
[TBL] [Abstract][Full Text] [Related]
3. Radiosurgery alone for 1-3 newly-diagnosed brain metastases from melanoma: impact of dose on treatment outcomes.
Rades D; Sehmisch L; Huttenlocher S; Blank O; Hornung D; Terheyden P; Gliemroth J; Schild SE
Anticancer Res; 2014 Sep; 34(9):5079-82. PubMed ID: 25202094
[TBL] [Abstract][Full Text] [Related]
4. A Score to Identify Patients with Brain Metastases from Colorectal Cancer Who May Benefit from Whole-brain Radiotherapy in Addition to Stereotactic Radiosurgery/Radiotherapy.
Rades D; Dziggel L; Blanck O; Gebauer N; Bartscht T; Schild SE
Anticancer Res; 2018 May; 38(5):3111-3114. PubMed ID: 29715148
[TBL] [Abstract][Full Text] [Related]
5. Predicting the Risk of New Cerebral Lesions After Stereotactic Radiosurgery (SRS) for Brain Metastases from Breast Cancer.
Dziggel L; Dahlke M; Janssen S; Hornung D; Blanck O; Khoa MT; Schild SE; Rades D
Anticancer Res; 2015 Dec; 35(12):6793-7. PubMed ID: 26637898
[TBL] [Abstract][Full Text] [Related]
6. Prognostic factors for survival in patients treated with stereotactic radiosurgery for recurrent brain metastases after prior whole brain radiotherapy.
Caballero JA; Sneed PK; Lamborn KR; Ma L; Denduluri S; Nakamura JL; Barani IJ; McDermott MW
Int J Radiat Oncol Biol Phys; 2012 May; 83(1):303-9. PubMed ID: 22079723
[TBL] [Abstract][Full Text] [Related]
7. Estimating survival of patients receiving radiosurgery alone for cerebral metastasis from melanoma.
Sehmisch L; Huttenlocher S; Schild SE; Rades D
J Dermatol; 2014 Oct; 41(10):918-21. PubMed ID: 25154301
[TBL] [Abstract][Full Text] [Related]
8. A matched-pair analysis comparing whole-brain radiotherapy plus stereotactic radiosurgery versus surgery plus whole-brain radiotherapy and a boost to the metastatic site for one or two brain metastases.
Rades D; Kueter JD; Pluemer A; Veninga T; Schild SE
Int J Radiat Oncol Biol Phys; 2009 Mar; 73(4):1077-81. PubMed ID: 18707817
[TBL] [Abstract][Full Text] [Related]
9. Survival and prognostic factors in patients with brain metastases from malignant melanoma.
Meier S; Baumert BG; Maier T; Wellis G; Burg G; Seifert B; Dummer R
Onkologie; 2004 Apr; 27(2):145-9. PubMed ID: 15138346
[TBL] [Abstract][Full Text] [Related]
10. A new scoring system to predicting the survival of patients treated with whole-brain radiotherapy for brain metastases.
Rades D; Dunst J; Schild SE
Strahlenther Onkol; 2008 May; 184(5):251-5. PubMed ID: 18427755
[TBL] [Abstract][Full Text] [Related]
11. Karnofsky performance status and lactate dehydrogenase predict the benefit of palliative whole-brain irradiation in patients with advanced intra- and extracranial metastases from malignant melanoma.
Partl R; Richtig E; Avian A; Berghold A; Kapp KS
Int J Radiat Oncol Biol Phys; 2013 Mar; 85(3):662-6. PubMed ID: 22901382
[TBL] [Abstract][Full Text] [Related]
12. Multimodality treatment of melanoma brain metastases incorporating stereotactic radiosurgery (SRS).
Samlowski WE; Watson GA; Wang M; Rao G; Klimo P; Boucher K; Shrieve DC; Jensen RL
Cancer; 2007 May; 109(9):1855-62. PubMed ID: 17351953
[TBL] [Abstract][Full Text] [Related]
13. Survival by radiation therapy oncology group recursive partitioning analysis class and treatment modality in patients with brain metastases from malignant melanoma: a retrospective study.
Buchsbaum JC; Suh JH; Lee SY; Chidel MA; Greskovich JF; Barnett GH
Cancer; 2002 Apr; 94(8):2265-72. PubMed ID: 12001126
[TBL] [Abstract][Full Text] [Related]
14. Retrospective study of 127 surgically treated patients with multiple brain metastases: indication, prognostic factors, and outcome.
Schackert G; Lindner C; Petschke S; Leimert M; Kirsch M
Acta Neurochir (Wien); 2013 Mar; 155(3):379-87. PubMed ID: 23314988
[TBL] [Abstract][Full Text] [Related]
15. Stereotactic radiosurgery alone versus resection plus whole-brain radiotherapy for 1 or 2 brain metastases in recursive partitioning analysis class 1 and 2 patients.
Rades D; Bohlen G; Pluemer A; Veninga T; Hanssens P; Dunst J; Schild SE
Cancer; 2007 Jun; 109(12):2515-21. PubMed ID: 17487853
[TBL] [Abstract][Full Text] [Related]
16. A New Predictive Tool for Optimization of the Treatment of Brain Metastases from Colorectal Cancer After Stereotactic Radiosurgery.
Rades D; Dahlke M; Gebauer N; Bartscht T; Hornung D; Trang NT; Phuong PC; Khoa MT; Gliemroth J
Anticancer Res; 2015 Oct; 35(10):5515-8. PubMed ID: 26408718
[TBL] [Abstract][Full Text] [Related]
17. Gamma knife radiosurgery for malignant melanoma brain metastases.
Seung SK; Sneed PK; McDermott MW; Shu HK; Leong SP; Chang S; Petti PL; Smith V; Verhey LJ; Wara WM; Phillips TL; Larson DA
Cancer J Sci Am; 1998; 4(2):103-9. PubMed ID: 9532412
[TBL] [Abstract][Full Text] [Related]
18. Do patients with very few brain metastases from breast cancer benefit from whole-brain radiotherapy in addition to radiosurgery?
Rades D; Huttenlocher S; Hornung D; Blanck O; Schild SE; Fischer D
Radiat Oncol; 2014 Dec; 9():267. PubMed ID: 25472758
[TBL] [Abstract][Full Text] [Related]
19. Predicting the Risk of Developing New Cerebral Lesions After Stereotactic Radiosurgery or Fractionated Stereotactic Radiotherapy for Brain Metastases from Renal Cell Carcinoma.
Rades D; Dziggel L; Blanck O; Gebauer N; Bartscht T; Schild SE
Anticancer Res; 2018 May; 38(5):2973-2976. PubMed ID: 29715126
[TBL] [Abstract][Full Text] [Related]
20. Linac radiosurgery versus whole brain radiotherapy for brain metastases. A survival comparison based on the RTOG recursive partitioning analysis.
Kocher M; Maarouf M; Bendel M; Voges J; Müller RP; Sturm V
Strahlenther Onkol; 2004 May; 180(5):263-7. PubMed ID: 15127155
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
